High-dose methotrexate as CNS prophylaxis in high-risk aggressive B-cell lymphoma

KL Lewis, LH Jakobsen, D Villa, KE Smedby… - Journal of Clinical …, 2023 - ascopubs.org
PURPOSE CNS progression or relapse is an uncommon but devastating complication of
aggressive B-cell lymphoma. There is no consensus regarding the optimal approach to CNS …
被引用次数：28 相关文章

High-Dose Methotrexate as CNS Prophylaxis in High-Risk Aggressive B-Cell Lymphoma

KL Lewis, LH Jakobsen, D Villa… - Journal of Clinical … - nottingham-repository.worktribe.com
PURPOSE CNS progression or relapse is an uncommon but devastating complication of
aggressive B-cell lymphoma. There is no consensus regarding the optimal approach to CNS …

High-Dose Methotrexate as CNS Prophylaxis in High-Risk Aggressive B-Cell Lymphoma.

KL Lewis, LH Jakobsen, D Villa, KE Smedby… - 2023 - austin.intersearch.com.au
CNS progression or relapse is an uncommon but devastating complication of aggressive B-
cell lymphoma. There is no consensus regarding the optimal approach to CNS prophylaxis …

High-Dose Methotrexate as CNS Prophylaxis in High-Risk Aggressive B-Cell Lymphoma

KL Lewis, LH Jakobsen, D Villa… - Journal of …, 2023 - research-repository.uwa.edu.au
PURPOSE CNS progression or relapse is an uncommon but devastating complication of
aggressive B-cell lymphoma. There is no consensus regarding the optimal approach to CNS …

High-Dose Methotrexate as CNS Prophylaxis in High-Risk Aggressive B-Cell Lymphoma

KL Lewis, LH Jakobsen, D Villa… - Journal of clinical …, 2023 - pubmed.ncbi.nlm.nih.gov
Purpose CNS progression or relapse is an uncommon but devastating complication of
aggressive B-cell lymphoma. There is no consensus regarding the optimal approach to CNS …

High-Dose Methotrexate as CNS Prophylaxis in High-Risk Aggressive B-Cell Lymphoma

KL Lewis, LH Jakobsen, D Villa… - Journal of Clinical …, 2023 - ingentaconnect.com
PURPOSE CNS progression or relapse is an uncommon but devastating complication of
aggressive B-cell lymphoma. There is no consensus regarding the optimal approach to CNS …

High-Dose Methotrexate as CNS Prophylaxis in High-Risk Aggressive B-Cell Lymphoma.

KL Lewis, LH Jakobsen, D Villa… - Journal of Clinical …, 2023 - europepmc.org
Purpose CNS progression or relapse is an uncommon but devastating complication of
aggressive B-cell lymphoma. There is no consensus regarding the optimal approach to CNS …

High-Dose Methotrexate as CNS Prophylaxis in High-Risk Aggressive B-Cell Lymphoma

KL Lewis, LH Jakobsen, D Villa, KE Smedby… - Journal of Clinical …, 2023 - vbn.aau.dk
PURPOSE CNS progression or relapse is an uncommon but devastating complication of
aggressive B-cell lymphoma. There is no consensus regarding the optimal approach to CNS …

High-Dose Methotrexate as CNS Prophylaxis in High-Risk Aggressive B-Cell Lymphoma

International CNS Prophylaxis … - Journal of Clinical …, 2023 - mayoclinic.elsevierpure.com
PURPOSE CNS progression or relapse is an uncommon but devastating complication of
aggressive B-cell lymphoma. There is no consensus regarding the optimal approach to CNS …
[PDF] researchgate.net

[PDF][PDF] High-Dose Methotrexate as CNS Prophylaxis in High-Risk Aggressive B-Cell Lymphoma

2023 - researchgate.net
ABSTRACT PURPOSE CNS progression or relapse is an uncommon but devastating
complication of aggressive B-cell lymphoma. There is no consensus regarding the optimal …